button bars forest bayes pooled summary circles
 
deaths (OS)

mHCC - (neo)adjuvant (NA) metastatic/advanced hepatocellular cancer (mHCC) mHCC - (neo)adjuvant (NA)

versus Standard of Care (SoC)
atezolizumab plus bevacizumab vs. Standard of Care (SoC) 1 certainty unassessable+42%
sintilimab vs. Standard of Care (SoC) 1 -

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons